Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/1999
12/02/1999WO1999061071A2 Assay in vivo of labeled triplex-forming oligonucleotides
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999053087A3 5'-modified nucleotides and the application thereof in molecular biology and medicine
12/02/1999WO1999051774A3 A method for obtaining a plant with a genetic lesion in a gene sequence
12/02/1999WO1999050448A3 Nucleic acid detection method
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999046047A3 Detection and characterization of microorganisms
12/02/1999WO1999044063B1 Tumor tissue microarrays for rapid molecular profiling
12/02/1999WO1999035262A3 Apoptosis inducing molecule ii
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999WO1999002544A8 Compounds having energy transfer function and method for dna base sequencing by using the same
12/02/1999DE19824280A1 Mass-spectrometric analysis of known gene mutations
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999CA2745939A1 Mara family helix-turn-helix domains and their methods of use
12/02/1999CA2745131A1 Aav5 vector and uses thereof
12/02/1999CA2333201A1 Microfabricated cell sorter
12/02/1999CA2333159A1 Method
12/02/1999CA2333006A1 Calmodulin related protein
12/02/1999CA2331553A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams
12/02/1999CA2329513A1 System for reproducing and modulating stability and turnover of rna molecules
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999CA2329140A1 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy
12/02/1999CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329057A1 Demonstrating resistance to antibiotics in microorganisms
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2328981A1 A novel str marker system for dna fingerprinting
12/02/1999CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999CA2328892A1 Tumor suppressor
12/02/1999CA2328491A1 Retroviral delivery system
12/02/1999CA2325462A1 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
12/02/1999CA2317697A1 Agent and method for modulation of cell migration
12/02/1999CA2270294A1 Reflex algorithm for early and cost effective diagnosis of myocardial infarctions suitable for automated diagnostic platforms
12/02/1999CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999EP0960947A1 Methods for judging the possibility of the onset of bovine leukemia and the resistance thereto
12/01/1999EP0960946A2 Method and apparatus for the determination of analytes
12/01/1999EP0960933A1 Measuring apparatus and process
12/01/1999EP0960337A1 Cathepsin K and breast cancer
12/01/1999EP0960335A2 Modulators of insulin receptor activity
12/01/1999EP0960216A1 Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
12/01/1999EP0960215A1 Nucleic acid sequencing
12/01/1999EP0960214A1 Diagnosis of disease state using mrna profiles
12/01/1999EP0960213A1 A METHOD OF DETECTING PROTEIN BY IMMUNO-aRNA
12/01/1999EP0960212A1 Gene identification method
12/01/1999EP0960211A1 Compositions and methods for the identification and treatment of patients at risk for heart failure
12/01/1999EP0960210A1 Diagnostic detection of nucleic acids
12/01/1999EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999EP0960207A1 Multiplex amplification of short tandem repeat loci
12/01/1999EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES
12/01/1999EP0960129A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF
12/01/1999EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999EP0960125A1 GALANIN RECEPTOR GalR2 AND NUCLEOTIDES ENCODING SAME
12/01/1999EP0960123A1 Sprouty protein and coding sequence
12/01/1999EP0960121A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
12/01/1999EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999EP0960114A1 Polymorphisms and new genes in the region of the human hemochromatosis gene
12/01/1999EP0959904A2 Hybrid compositions for intracellular targeting
12/01/1999EP0959877A1 Correction of genetic defects using chemical chaperones
12/01/1999EP0959769A1 Apparatus for the iris acquiring images
12/01/1999EP0833944A4 Nucleic acid ligands that bind to and inhibit dna polymerases
12/01/1999EP0763130A4 Biological assay for microbial contamination
12/01/1999EP0740708A4 Design of drugs involving receptor-ligand-dna interactions
12/01/1999EP0656063B1 Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof
12/01/1999CN1237211A Method and device for detecting toxic and mutagenic effect of chemicals and mixtures of substances using immobilized luminescent
12/01/1999CN1237207A Chrysosporium cellulase and methods of use
11/1999
11/30/1999US5995645 Method of cancer cell detection
11/30/1999US5994552 Process for the production of substituted thiazoline-dioxetan substrates and use thereof
11/30/1999US5994529 Glioma-associated nucleic acid probes
11/30/1999US5994528 Method of detecting gene expression and/or of preventing such expression in cells
11/30/1999US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994319 Synergistic mixture
11/30/1999US5994315 Low adenosine agent, composition, kit and method for treatment of airway disease
11/30/1999US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999US5994300 Vascular endothelial cell growth factor C subunit
11/30/1999US5994149 Rapid test employing an adhesive slide
11/30/1999US5994140 Stable coagulation controls
11/30/1999US5994137 Obtaining mycobacteriophage with an escherichia bacteriophage cosmid and a transposon inserted in a non-essential region, infecting the bacterium with the phasmid to deliver the transposon to the bacterium chromosome causing gene mutations
11/30/1999US5994131 Incubating a test compound with epithial cells that will express the human op-1 protein, which induces endochondral bone formation; measuring amount of protein expressed from cells with test compound, comparing values to control cells
11/30/1999US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999US5994117 Use of Bacillus Subtilis as an endophyte for the control of diseases caused by fungi
11/30/1999US5994114 A polynucleotide which codes for a protein having taxadiene synthase activity; chemotherapy
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
11/30/1999US5994103 Human stanniocalcin-alpha
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994097 Polynucleotide encoding human G-protein coupled receptor
11/30/1999US5994096 Regulator
11/30/1999US5994095 MTS2 gene
11/30/1999US5994093 Detection and correction of abnormalities of cells having decreased level of Glycine N-methyltransferase
11/30/1999US5994092 Use of β-D-galactopyranosyl-D-xyloses for the preparation of compositions and solutions intended to the evaluation of intestinal lactase, and production process
11/30/1999US5994091 Optical sensor for enzyme and enzyme substrates